News

BioThrax vaccine is licensed by the US Food and Drug Administration (FDA) to protect against anthrax infection. Under this award, the initial deliveries are likely to begin in

Benefix RTS can be stored for up to two years at room temperature (2-30°C) for about two years, thereby providing more convenience to haemophilia B patients, europeanpharmaceuticalreview reported.

The settlement includes a license by MDCO to Teva and its affiliates under which Teva may launch a generic bivalirudin product. Teva admits that the two patents asserted

Cleviprex is an intravenous dihydropyridine calcium channel blocker, which helps in reduction of blood pressure when oral therapy is not feasible. According to the company, the new formulation

Miravirsen, which is developed using Locked Nucleic Acid (LNA) Drug Platform, is an inhibitor of miR-122, a liver specific microRNA that the Hepatitis C virus requires for replication.

A web-based repository has been developed by ICON, which will help facilitate analysis of clinical trial data, thereby resulting in better efficiency across the business, siliconrepublic.com reported. Oracle

SEP has acquired a minority stake in Exco InTouch which will use the funds to drive its growth in the clinical technology sector, especially in the mobile patient

Galapagos will develop new candidate drugs against the targets. As per the agreement, Servier can exclusively license each small molecule program after the completion of pre-clinical development by

Russian government has signed the agreement on behalf of Volgograd State Medical University, which will work with NIPER on pharmaceutical research, pharmabiz.com reported. NIPER director Professor KK Bhutani